2026年全球病理服務市場報告

近年來，病理服務市場規模持續強勁成長。預計該市場規模將從2025年的337.8億美元成長至2026年的361.4億美元，複合年成長率（CAGR）為7.0%。成長要素包括：對人工檢測程序的依賴、診斷工作流程中自動化程度有限、分子診斷技術普及率低、熟練的實驗室技術人員短缺以及醫療檢測基礎設施分散等。

預計未來幾年病理服務市場將維持強勁成長，年複合成長率（CAGR）將達到7.2%，2030年市場規模將達到477.9億美元。預測期內的成長要素包括：人工智慧診斷系統的日益普及、精準醫療的廣泛應用、雲端病理平台的快速發展、預防性健康篩檢需求的不斷成長，以及多體學和先進分子檢測技術的融合。預測期內的關鍵趨勢包括：分子和基因檢測在精準診斷中的應用日益廣泛、病理工作流程向整合檢查室自動化轉型、分散式和即時檢驗（POC）病理服務的擴展、對基於多體學的疾病檢測方法的需求不斷成長，以及預測分析在疾病早期檢測和持續監測中的應用日益廣泛。

個人化和精準醫療的擴展預計將推動病理服務市場的成長。個人化和精準醫療是指根據個人獨特的基因、分子和臨床特徵，客製化疾病預防、診斷和治療的醫療方法。精準醫療的日益普及主要得益於基因測序技術的快速發展。這項技術顯著降低了產生患者特異性基因數據的成本和時間，擴大了其在醫療保健系統中的臨床應用。個人化和精準醫療的擴展正在推動病理服務需求的成長。這是因為病理服務對於進行基因檢測、生物標記評估和分子診斷至關重要，而這些對於制定個人化治療策略至關重要。例如，據美國醫院和醫療保健組織「個人化醫療聯盟」（Personalized Medicine Coalition）稱，截至2024年2月，美國食品藥物管理局（FDA）在2023年批准了16種針對罕見疾病患者的新型個人化療法，高於2022年的6種。因此，個人化和精準醫療的擴展正在推動病理服務市場的成長。

病理服務市場的領導者正致力於拓展人工智慧 (AI) 驅動的數位病理解決方案，以提高診斷準確性、簡化檢查室工作流程，並支援病理學家進行疾病檢測和分析。 AI 驅動的數位病理解決方案是指結合數位影像、雲端平台和機器學習演算法的先進技術，用於輔助病理觀察解讀、病例審查和臨床決策。例如，2026 年 2 月，美國生命科學和診斷公司 Laboratory Corporation of America Holdings 擴大了與美國生物技術公司 PathAI 的合作，在其整個檢查室網路中部署了經 FDA 批准的數位病理影像管理系統 AISight Dx。該系統透過個案管理、切片註釋、即時協作以及與檢查室資訊系統的無縫整合，支援數位病理工作流程。該平台將 AI 驅動的影像分析與安全且擴充性的基礎設施相結合，從而提高診斷準確性、減少人為錯誤並提升營運效率。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球病理服務市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施、互聯生態系統
  • 工業4.0和智慧製造
• 主要趨勢
  • 擴大分子和基因檢測在詳細診斷的應用
  • 病理工作流程向整合實驗室自動化的過渡正在推進。
  • 擴大分散式和即時病理服務
  • 基於多組體學的疾病檢測方法的需求日益成長
  • 擴大預測分析在疾病早期檢測與監測的應用

第5章 終端用戶產業市場分析

• 醫院
• 診斷檢查室
• 研究機構
• 診所
• 居家照護環境

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球病理服務市場：PESTEL 分析（政治、經濟、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球病理服務市場：規模、對比及成長率分析
• 全球病理服務市場表現：規模與成長，2020-2025年
• 全球病理服務市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按服務類型
• 臨床病理學、解剖病理學、分子病理學、細胞病理學、法醫學病理學
• 按測試類型
• 血液檢查、尿液檢查、組織切片檢查、基因檢測、微生物檢測、免疫學檢測
• 透過技術
• 檢查室自動化、數位病理、分子診斷技術、人工智慧和數據分析
• 透過使用
• 疾病診斷、藥物發現與開發及其他應用
• 最終用戶
• 醫院、診斷檢測機構、研究機構、診所和居家醫療機構
• 按類型細分：臨床病理學
• 血液檢查、臨床化學檢查、微生物學檢查、免疫學和血清學檢查、血液凝固檢驗、尿液檢查分析、毒理學檢查、血庫和輸血服務。
• 按類型細分：解剖病理學
• 組織病理學、外科病理學、皮膚病理學、神經病理學、胃腸道病理學、腎臟病理學、婦科病理學、屍檢病理學
• 按類型細分：分子病理學
• 聚合酵素鏈鎖反應(PCR) 檢測、次世代定序(NGS)、基因檢測、伴隨診斷、感染疾病分子診斷、藥物基因體藥物基因體學檢測、產前分子檢測。
• 按類型細分：細胞病理學
• 婦科細胞學、非婦科細胞學、細針穿刺細胞學、脫落細胞學、液態細胞學、尿液細胞學、呼吸道細胞學、乳房細胞學
• 按類型細分：法醫學病理學
• 屍檢、毒理學、法醫學病理學、去氧核糖核酸（DNA）分析、彈道和創傷分析、猝死調查、法醫學人類學、法醫學調查

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 病理服務市場：競爭格局及市場佔有率（2024 年）
• 病理服務市場：公司估值矩陣
• 病理服務市場：公司概況
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Eurofins Scientific SE
  • Sonic Healthcare Limited
  • Charles River Laboratories International Inc.

第37章 其他大型企業和創新企業

• Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners PA, MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年病理服務市場：提供新機會的國家
• 病理服務市場展望（2030）：新興細分市場機會
• 病理服務市場展望（2030 年）：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Pathology services are specialized diagnostic healthcare services focused on examining biological samples, body fluids, and tissues to identify diseases and medical conditions. These services assist healthcare providers in accurately diagnosing illnesses, tracking disease progression, and selecting suitable treatment approaches. Pathology services are essential for the detection of cancer, infectious diseases, genetic abnormalities, and chronic health conditions while also supporting preventive care and personalized medicine initiatives.

The primary service categories of pathology services include clinical pathology, anatomical pathology, molecular pathology, cytopathology, and forensic pathology. Clinical pathology refers to laboratory-based medical services that focus on the examination of bodily fluids such as blood, urine, and other specimens to diagnose, monitor, and treat diseases. These services are classified by test type, including blood testing, urine testing, tissue biopsy testing, genetic testing, microbiological testing, and immunological testing, and are supported by technologies such as laboratory automation, digital pathology, molecular diagnostic technologies, and artificial intelligence with data analytics. Their applications include disease diagnosis, drug discovery and development, and other related uses, while the key end users comprise hospitals, diagnostic laboratories, research institutions, physician offices, and homecare settings.

Tariffs are influencing the pathology services market by increasing the cost of imported diagnostic reagents, laboratory instruments, testing kits, and advanced molecular pathology equipment used in both clinical and research applications. This is slowing laboratory expansion and driving up operational expenses, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments such as molecular pathology, anatomical pathology, and laboratory automation under technology are most affected due to their reliance on globally sourced high-end systems and consumables. However, tariffs are also promoting domestic production of diagnostic kits, diversification of regional suppliers, and greater investment in local laboratory infrastructure, ultimately strengthening long-term resilience and self-sufficiency in pathology service delivery.

The pathology services market size has grown strongly in recent years. It will grow from $33.78 billion in 2025 to $36.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to dependence on manual laboratory testing procedures, limited automation in diagnostic workflows, low adoption of molecular diagnostic technologies, shortage of skilled laboratory personnel, and fragmented healthcare laboratory infrastructure.

The pathology services market size is expected to see strong growth in the next few years. It will grow to $47.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to AI-enabled diagnostic interpretation systems, expansion of precision medicine adoption, growth in cloud-based pathology platforms, increasing demand for preventive healthcare screening, and integration of multi-omics and advanced molecular testing approaches. Major trends in the forecast period include rising adoption of molecular and genetic testing for precision diagnostics, increasing shift toward integrated laboratory automation in pathology workflows, expansion of decentralized and point-of-care pathology testing services, growing demand for multi-omics-based disease detection methods, and increasing use of predictive analytics for early disease identification and continuous monitoring.

The expansion of personalized and precision medicine is expected to propel the growth of the pathology services market going forward. Personalized and precision medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual's unique genetic, molecular, and clinical profile. The increasing adoption of precision medicine is mainly fueled by rapid progress in genomic sequencing technologies, which have substantially lowered the cost and time required to generate patient-specific genetic data, enabling wider clinical use across healthcare systems. The growing expansion of personalized and precision medicine increases demand for pathology services, as they are crucial for performing genetic testing, biomarker evaluation, and molecular diagnostics that support individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six in 2022. Therefore, the expansion of personalized and precision medicine is driving the growth of the pathology services market.

Leading companies operating in the pathology services market are focusing on expanding artificial intelligence (AI)-powered digital pathology solutions to improve diagnostic precision, streamline laboratory workflows, and support pathologists in disease detection and analysis. AI-powered digital pathology solutions refer to advanced technologies that combine digital imaging, cloud-based platforms, and machine learning algorithms to assist in pathology interpretation, case review, and clinical decision-making. For example, in February 2026, Laboratory Corporation of America Holdings, a US-based life sciences and diagnostic company, expanded its collaboration with PathAI, a US-based biotechnology company, to deploy the AISight Dx, an FDA-cleared digital pathology image management system, across its laboratory network. It supports digital pathology workflows through case management, slide annotation, real-time collaboration, and seamless integration with laboratory information systems. The platform combines AI-driven image analysis with secure and scalable infrastructure to improve diagnostic accuracy, reduce manual errors, and enhance operational efficiency.

In July 2024, Quest Diagnostics, a US-based provider of diagnostic information services, laboratory testing, and pathology services, acquired the laboratory assets of PathAI Diagnostics from PathAI for an undisclosed amount. Through this acquisition, Quest Diagnostics aims to accelerate the integration of artificial intelligence and digital pathology technologies to improve cancer diagnosis and further enhance diagnostic efficiency and accuracy. PathAI is a US-based provider of digital and artificial intelligence-enabled pathology laboratory services focused on advancing precision diagnostics and supporting clinical applications as well as biopharmaceutical research.

Major companies operating in the pathology services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International Inc., Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs

North America was the dominant region in the pathology services market in 2025. Asia-Pacific is expected to be the rapidly expanding regionin the forecast period. The regions covered in the pathology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pathology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pathology services market includes revenues earned by entities by providing services such as laboratory testing, diagnostic analysis, specimen collection, histopathology, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering, such as diagnostic kits, reagents, and testing consumables. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pathology services market research report is one of a series of new reports from The Business Research Company that provides pathology services market statistics, including pathology services industry global market size, regional shares, competitors with a pathology services market share, detailed pathology services market segments, market trends and opportunities, and any further data you may need to thrive in the pathology services industry. This pathology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pathology Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pathology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pathology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pathology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service Type: Clinical Pathology; Anatomical Pathology; Molecular Pathology; Cytopathology; Forensic Pathology
• 2) By Test Type: Blood Testing; Urine Testing; Tissue Biopsy Testing; Genetic Testing; Microbiological Testing; Immunological Testing
• 3) By Technology: Laboratory Automation; Digital Pathology; Molecular Diagnostics Technologies; Artificial Intelligence And Data Analytics
• 4) By Application: Disease Diagnosis; Drug Discovery And Development; Other Applications
• 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutions; Physician Offices; Homecare Settings
• Subsegments:
• 1) By Clinical Pathology: Hematology Testing; Clinical Chemistry; Microbiology Testing; Immunology And Serology; Coagulation Testing; Urinalysis; Toxicology Testing; Blood Banking And Transfusion Services
• 2) By Anatomical Pathology: Histopathology; Surgical Pathology; Dermatopathology; Neuropathology; Gastrointestinal Pathology; Renal Pathology; Gynecological Pathology; Autopsy Pathology
• 3) By Molecular Pathology: Polymerase Chain Reaction (PCR) Testing; Next-Generation Sequencing (NGS); Genetic Testing; Companion Diagnostics; Infectious Disease Molecular Diagnostics; Oncology Molecular Diagnostics; Pharmacogenomics Testing; Prenatal Molecular Testing
• 4) By Cytopathology: Gynecologic Cytology; Non-Gynecologic Cytology; Fine Needle Aspiration (FNA) Cytology; Exfoliative Cytology; Liquid-Based Cytology; Urine Cytology; Respiratory Cytology; Breast Cytology
• 5) By Forensic Pathology: Postmortem Examination; Toxicological Analysis; Forensic Histopathology; Deoxyribonucleic Acid Profiling; Ballistic And Trauma Analysis; Sudden Death Investigation; Forensic Anthropology; Medico-Legal Investigation
• Companies Mentioned: Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Sonic Healthcare Limited; Charles River Laboratories International Inc.; Healius Limited; ARUP Laboratories Inc.; Apollo Diagnostics; Mayo Clinic Laboratories; Fulgent Genetics Inc.; ACL Laboratories; Spectrum Healthcare Partners P.A.; MedGenome Labs Ltd.; ACM Global Laboratories Inc.; Guangzhou KingMed Diagnostics Group Co. Ltd.; Krsnaa Diagnostics Limited; Synnovis Group LLP; Dr Lal PathLabs; SYNLAB; Unilabs
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pathology Services Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pathology Services Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pathology Services Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pathology Services Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Molecular And Genetic Testing For Precision Diagnostics
  • 4.2.2 Increasing Shift Toward Integrated Laboratory Automation In Pathology Workflows
  • 4.2.3 Expansion Of Decentralized And Point Of Care Pathology Testing Services
  • 4.2.4 Growing Demand For Multi Omics Based Disease Detection Approaches
  • 4.2.5 Increasing Use Of Predictive Analytics For Early Disease Identification And Monitoring

5. Pathology Services Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Research Institutions
• 5.4 Physician Offices
• 5.5 Homecare Settings

6. Pathology Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pathology Services Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pathology Services PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pathology Services Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pathology Services Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pathology Services Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pathology Services Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pathology Services Market Segmentation

• 9.1. Global Pathology Services Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Pathology, Anatomical Pathology, Molecular Pathology, Cytopathology, Forensic Pathology
• 9.2. Global Pathology Services Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Testing, Urine Testing, Tissue Biopsy Testing, Genetic Testing, Microbiological Testing, Immunological Testing
• 9.3. Global Pathology Services Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Automation, Digital Pathology, Molecular Diagnostics Technologies, Artificial Intelligence And Data Analytics
• 9.4. Global Pathology Services Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disease Diagnosis, Drug Discovery And Development, Other Applications
• 9.5. Global Pathology Services Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Research Institutions, Physician Offices, Homecare Settings
• 9.6. Global Pathology Services Market, Sub-Segmentation Of Clinical Pathology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hematology Testing, Clinical Chemistry, Microbiology Testing, Immunology And Serology, Coagulation Testing, Urinalysis, Toxicology Testing, Blood Banking And Transfusion Services
• 9.7. Global Pathology Services Market, Sub-Segmentation Of Anatomical Pathology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Histopathology, Surgical Pathology, Dermatopathology, Neuropathology, Gastrointestinal Pathology, Renal Pathology, Gynecological Pathology, Autopsy Pathology
• 9.8. Global Pathology Services Market, Sub-Segmentation Of Molecular Pathology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction (PCR) Testing, Next-Generation Sequencing (NGS), Genetic Testing, Companion Diagnostics, Infectious Disease Molecular Diagnostics, Oncology Molecular Diagnostics, Pharmacogenomics Testing, Prenatal Molecular Testing
• 9.9. Global Pathology Services Market, Sub-Segmentation Of Cytopathology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gynecologic Cytology, Non-Gynecologic Cytology, Fine Needle Aspiration (FNA) Cytology, Exfoliative Cytology, Liquid-Based Cytology, Urine Cytology, Respiratory Cytology, Breast Cytology
• 9.10. Global Pathology Services Market, Sub-Segmentation Of Forensic Pathology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Postmortem Examination, Toxicological Analysis, Forensic Histopathology, Deoxyribonucleic Acid Profiling, Ballistic And Trauma Analysis, Sudden Death Investigation, Forensic Anthropology, Medico-Legal Investigation

10. Pathology Services Market Regional And Country Analysis

• 10.1. Global Pathology Services Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pathology Services Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pathology Services Market

• 11.1. Asia-Pacific Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pathology Services Market

• 12.1. China Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pathology Services Market

• 13.1. India Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pathology Services Market

• 14.1. Japan Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pathology Services Market

• 15.1. Australia Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pathology Services Market

• 16.1. Indonesia Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pathology Services Market

• 17.1. South Korea Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pathology Services Market

• 18.1. Taiwan Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pathology Services Market

• 19.1. South East Asia Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pathology Services Market

• 20.1. Western Europe Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pathology Services Market

• 21.1. UK Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pathology Services Market

• 22.1. Germany Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pathology Services Market

• 23.1. France Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pathology Services Market

• 24.1. Italy Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pathology Services Market

• 25.1. Spain Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pathology Services Market

• 26.1. Eastern Europe Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pathology Services Market

• 27.1. Russia Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pathology Services Market

• 28.1. North America Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pathology Services Market

• 29.1. USA Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pathology Services Market

• 30.1. Canada Pathology Services Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pathology Services Market

• 31.1. South America Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pathology Services Market

• 32.1. Brazil Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pathology Services Market

• 33.1. Middle East Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pathology Services Market

• 34.1. Africa Pathology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pathology Services Market, Segmentation By Service Type, Segmentation By Test Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pathology Services Market Regulatory and Investment Landscape

36. Pathology Services Market Competitive Landscape And Company Profiles

• 36.1. Pathology Services Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pathology Services Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pathology Services Market Company Profiles
  • 36.3.1. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sonic Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pathology Services Market Other Major And Innovative Companies

• Healius Limited, ARUP Laboratories Inc., Apollo Diagnostics, Mayo Clinic Laboratories, Fulgent Genetics Inc., ACL Laboratories, Spectrum Healthcare Partners P.A., MedGenome Labs Ltd., ACM Global Laboratories Inc., Guangzhou KingMed Diagnostics Group Co. Ltd., Krsnaa Diagnostics Limited, Synnovis Group LLP, Dr Lal PathLabs, SYNLAB, Unilabs

38. Global Pathology Services Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Pathology Services Market

41. Pathology Services Market High Potential Countries, Segments and Strategies

• 41.1 Pathology Services Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Pathology Services Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Pathology Services Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer